نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - enoxaparin sodium 150 mg/ml;   - solution for injection - 150 mg/ml - active: enoxaparin sodium 150 mg/ml   excipient: water for injection - - treatment of venous thromboembolic disease. - prevention of thrombus formation in the extra-corporeal circulation during haemodialysis.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - clobetasol propionate 0.5 mg/g;  ;  ;   - shampoo - 0.5 mg/g - active: clobetasol propionate 0.5 mg/g       excipient: citric acid monohydrate coco-betaine ethanol polyquaternium-10 purified water sodium citrate dihydrate sodium laureth sulfate - the topical treatment of moderate to severe scalp psoriasis.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amiodarone hydrochloride 100mg;  ;   - tablet - 100 mg - active: amiodarone hydrochloride 100mg     excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch povidone - tachyarrhythmias associated with wolff-parkinson-white syndrome. atrial flutter and fibrillation when other agents cannot be used. all types of tachyarrhythmias of paroxysmal nature including: supraventricular, nodal and ventricular tachycardias, ventricular fibrillation; when other agents cannot be used. tablets are used for stabilisation and long term treatment.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amiodarone hydrochloride 200mg;  ;   - tablet - 200 mg - active: amiodarone hydrochloride 200mg     excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch povidone - tachyarrhythmias associated with wolff-parkinson-white syndrome. atrial flutter and fibrillation when other agents cannot be used. all types of tachyarrhythmias of paroxysmal nature including: supraventricular, nodal and ventricular tachycardias, ventricular fibrillation; when other agents cannot be used. tablets are used for stabilisation and long term treatment.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amiodarone hydrochloride 50 mg/ml;   - solution for injection - 150mg/3ml - active: amiodarone hydrochloride 50 mg/ml   excipient: benzyl alcohol polysorbate 80 water for injection - tachyarrhythmias associated with wolff-parkinson-white syndrome. all types of tachyarrhythmias including; supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation; ventricular fibrillation; when other agents cannot be used. the injection is to be used when a rapid response is required.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - dactinomycin 0.5mg;   - powder for injection - 0.5 mg - active: dactinomycin 0.5mg   excipient: mannitol

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - glibenclamide 5mg;  ; glibenclamide 5mg - tablet - 5 mg - active: glibenclamide 5mg   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch pregelatinised maize starch purified talc active: glibenclamide 5mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch purified talc

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flupentixol decanoate 20 mg/ml - injection (depot) - 20 mg/ml - active: flupentixol decanoate 20 mg/ml excipient: vegetable oil - fluanxol injection is a depot neuroleptic preparation and is indicated in the treatment and maintenance of schizophrenic patients, especially those who are unreliable in taking the medicine prescribed for them.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flupentixol decanoate 100 mg/ml - injection (depot) - 100 mg/ml - active: flupentixol decanoate 100 mg/ml excipient: vegetable oil - fluanxol concentrated injection is a depot neuroleptic preparation and is indicated in the treatment of moderate to severe schizophrenia and allied psychoses. patients for whom the drug is especially appropriate are: 1. those believed by the physician to be unreliable in taking oral medication. 2. patients who are already receiving treatment with fluanxol injection at high dose levels and who may experience discomfort as a result of the large injection volume. 3. patients who hitherto could not receive effective treatment with depot neuroleptics because of the high doses, and hence large volumes, required to achieve satisfactory therapeutic blood levels. features of the illness most likely to benefit are hallucinations, paranoid delusions, apathy, inertia, withdrawal and anxiety

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sodium valproate 40 mg/ml - syrup - 200 mg/5ml - active: sodium valproate 40 mg/ml excipient: cherry flavour 17.40.0740 ponceau 4r purified water saccharin sodium sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate sorbitol sucrose - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.